NIHR Funding for Kidney Care App Study at Portsmouth NHS Trust

Why It Matters

The trial provides critical evidence on whether a patient‑focused digital tool can improve chronic kidney disease management without deepening existing health disparities, informing broader NHS digital health strategies.

Key Takeaways

• NIHR grants ~£100k ($128k) to study MyRenalCare app
• Study will compare 1,000 app users with 1,000 standard-care patients
• Research focuses on digital care equity across diverse kidney patients
• Findings aim to guide NHS rollout of inclusive digital kidney services
• Patient interviews will assess real‑world experience and health inequality impact

Pulse Analysis

Chronic kidney disease (CKD) affects roughly 3 % of the UK adult population, imposing ongoing monitoring, medication adjustments, and lifestyle constraints. As the NHS accelerates digital transformation, mobile applications have emerged as a way to shift routine management from clinics to patients’ homes. MyRenalCare, created at the Wessex Kidney Centre after direct patient feedback, offers personalized dashboards, medication reminders, and remote data sharing, already supporting thousands of users. The app exemplifies how condition‑specific software can reduce appointment burden while keeping clinicians informed.

The INCLUDE‑CKD trial, funded by a near‑£100,000 (about $128,000) NIHR grant, will enroll roughly 1,000 MyRenalCare participants and a matched cohort receiving conventional care. Over twelve months, researchers will collect usage metrics, clinical outcomes, and qualitative interviews with patients and staff. By concentrating on diverse socioeconomic and ethnic groups, the study seeks to uncover whether the digital platform narrows or widens existing health disparities. Early indicators suggest that flexible, home‑based tools can improve adherence, but rigorous evidence is needed to confirm equitable impact.

If the trial demonstrates that MyRenalCare delivers comparable or better outcomes without amplifying inequality, it could become a template for NHS-wide digital rollouts in other chronic conditions. Policymakers would gain a data‑driven case for investing in interoperable, patient‑centred apps that align with the NHS Long Term Plan’s ambition for a more inclusive, technology‑enabled service model. Conversely, any identified gaps would highlight the need for targeted training, broadband access, or language localisation, ensuring that future digital health investments do not leave vulnerable populations behind.